Skip to main content

Interlaboratory comparison in HercepTest assessment of HER2 protein status in invasive breast carcinoma fixed with various formalin-based fixatives.

Hashizume K, Hatanaka Y, Kamihara Y, Kato T, Hata S, Akashi S, Koyatsu J, Tani Y, Tsujimoto M, Tsuda H

Publication: Appl Immunohistochem Mol Morphol (2003) • Vol 11 • Page 339-44PMID: 14663361View on PubMed

Purpose

The purpose of this paper was to determine the effects of formalin formula and duration on human epidermal growth factor receptor 2 (HER2) immunohistochemial (IHC) staining of breast carcinoma specimens.

Conclusion

Regardless of formalin formula, HER2 overexpression rates were at or near the expected range (20-30%) using the HercepTest. Only moderate agreement was observed between fixation times of 1 and 7 days. For most of the discordant results, specimens had a weaker HercepTest score after 7 days of fixation compared to 1 day. The CB11 antibody and the HercepTest showed substantial agreement in HER2 status determination, while the TAB250 antibody only showed fair agreement with HercepTest.

Studies (1)

Purpose

The purpose of this study was to determine the effects of formalin formula and duration on HER2 IHC staining of breast carcinoma specimens. In addition, the use of different antibodies for HER2 status determination was examined.

Summary of Findings

Regardless of formalin formula, HER2 overexpression rates were at or near the expected range (20-30%) using the HercepTest. Fixation of the same specimens for 1 or 7 days in 20% unbuffered formalin revealed discordant results for 11 of the 36 specimens indicating only moderate agreement. For 8 of the discordant results, specimens had a weaker HercepTest score after 7 days of fixation compared to 1 day. Notably, all 7 specimens scored as 3+ after 1 day of fixation were also scored as 3+ after 7 days of fixation, however the staining intensity was somewhat decreased. The CB11 antibody and the HercepTest showed substantial agreement in HER2 status determination, while the TAB250 antibody only showed fair agreement with HercepTest.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationConcentration of fixative
    15% neutral buffered formalin
    20% unbuffered formalin
    Biospecimen PreservationTime in fixative
    1 d
    7 d
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Formalin (unbuffered)
    Immunohistochemistry SpecificType of antibody
    CB11
    HercepTest
    TAB250